UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
$1.65B |
| 2 |
Accenture
ACN
|
$1.54B |
| 3 |
Linde
LIN
|
$1.24B |
| 4 |
Prologis
PLD
|
$1.08B |
| 5 |
Microsoft
MSFT
|
$914M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$809M |
| 2 |
Blackrock
BLK
|
$809M |
| 3 |
Lam Research
LRCX
|
$735M |
| 4 |
Meta Platforms (Facebook)
META
|
$563M |
| 5 |
UBS Group
UBS
|
$411M |
Sector Composition
| 1 | Technology | 33.21% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRGX
2676
DELISTED
CARGO Therapeutics
CRGX
| $208K | ﹤0.01% |
11,262
-1,772
| -14% | -$32.7K |
|
2677
Brown-Forman Class A
BF.A
$13.6B
| $204K | ﹤0.01% |
+4,238
| New | +$204K |
|
2678
AMC Networks
AMCX
$332M
| $203K | ﹤0.01% |
23,356
-6,888
| -23% | -$59.9K |
|
2679
Nuveen Credit Strategies Income Fund
JQC
$749M
| $203K | ﹤0.01% |
35,000
-25,000
| -42% | -$145K |
|
|
NCV
2680
Virtus Convertible & Income Fund
NCV
$333M
| $193K | ﹤0.01% |
13,750
-11,250
| -45% | -$158K |
|
|
GHY
2681
PGIM Global High Yield Fund
GHY
$547M
| $192K | ﹤0.01% |
15,000
-10,000
| -40% | -$128K |
|
2682
Lexicon Pharmaceuticals
LXRX
$389M
| $189K | ﹤0.01% |
+120,387
| New | +$189K |
|
2683
Root
ROOT
$1.43B
| $187K | ﹤0.01% |
4,962
-1,228
| -20% | -$46.4K |
|
|
FAX
2684
abrdn Asia-Pacific Income Fund
FAX
$675M
| $174K | ﹤0.01% |
10,000
-10,833
| -52% | -$188K |
|
|
NKLA
2685
DELISTED
Nikola Corporation Common Stock
NKLA
| $172K | ﹤0.01% |
37,642
-4,097
| -10% | -$18.8K |
|
|
CLCO
2686
Cool Company
CLCO
$394M
| $163K | ﹤0.01% |
14,456
-96
| -0.7% | -$1.08K |
|
|
MOMO
2687
Hello Group
MOMO
$1.36B
| $160K | ﹤0.01% |
21,030
+10,818
| +106% | +$82.3K |
|
2688
B. Riley Financial
RILY
$151M
| $151K | ﹤0.01% |
28,677
-2,772
| -9% | -$14.6K |
|
2689
Similarweb
SMWB
$822M
| $141K | ﹤0.01% |
15,912
-3,138
| -16% | -$27.7K |
|
2690
Monte Rosa Therapeutics
GLUE
$309M
| $128K | ﹤0.01% |
24,100
+8,500
| +54% | +$45.1K |
|
|
CRDL
2691
Cardiol Therapeutics
CRDL
$89.6M
| $109K | ﹤0.01% |
55,000
| – | – |
|
2692
Suzano
SUZ
$11.9B
| $107K | ﹤0.01% |
+10,686
| New | +$107K |
|
|
OKLO
2693
Oklo
OKLO
$10.3B
| $104K | ﹤0.01% |
+12,881
| New | +$104K |
|
2694
1stdibs.com
DIBS
$101M
| $103K | ﹤0.01% |
23,361
| – | – |
|
2695
Holley
HLLY
$464M
| $97.9K | ﹤0.01% |
33,183
-16,812
| -34% | -$49.6K |
|
2696
Absci
ABSI
$362M
| $91.1K | ﹤0.01% |
23,850
| – | – |
|
2697
Bilibili
BILI
$9.22B
| $82.5K | ﹤0.01% |
3,528
+735
| +26% | +$17.2K |
|
2698
Black Diamond Therapeutics
BDTX
$166M
| $80.9K | ﹤0.01% |
18,600
| – | – |
|
|
JKS
2699
JinkoSolar
JKS
$1.32B
| $64.4K | ﹤0.01% |
2,400
-5,761
| -71% | -$155K |
|
|
VNET
2700
VNET Group
VNET
$2.11B
| $60.9K | ﹤0.01% |
14,931
| – | – |
|